In the absence of effective interventions to prevent preterm births, improved survival of
infants who are born at the biological limits of viability has relied on advances in perinatal …

Background Bronchopulmonary dysplasia (BPD) is the result of a complex process in which
several prenatal and/or postnatal factors interfere with lower respiratory tract development …

Advances in the management of respiratory distress syndrome (RDS) ensure that clinicians
must continue to revise current practice. We report the third update of the European …

METHODS Retrospective cohort study of infants born from 22 to 29 weeks' gestation in 2018
at 715 US hospitals in the Vermont Oxford Network. Rates of BPD, major neonatal …

Background Assisted ventilation for extremely preterm infants (< 28 weeks of gestation) has
become less invasive, but it is unclear whether such developments in care are associated …

Objective: The aim of this study was to determine which initial surgical treatment results in
the lowest rate of death or neurodevelopmental impairment (NDI) in premature infants with …

BACKGROUND The use of antenatal steroid therapy is common in pregnancy. In early
pregnancy, steroids may be used in women for the treatment of recurrent miscarriage or fetal …

Although bronchopulmonary dysplasia (BPD) is the most frequent adverse outcome for
infants born at< 30 weeks gestational age, there remain major gaps in understanding the …

Respiratory distress syndrome (RDS) care pathways evolve slowly as new evidence
emerges. We report the sixth version of “European Guidelines for the Management of RDS” …

Importance The safety of postnatal corticosteroids used for prevention of bronchopulmonary
dysplasia (BPD) in preterm neonates is a controversial matter, and a risk-benefit balance …